Cargando…
Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment
Dendritic cells (DCs) are the most potent antigen-presenting cells and are the key initiator of tumor-specific immune responses. These characteristics are exploited by DC therapy, where DCs are ex vivo loaded with tumor-associated antigens (TAAs) and used to induce tumor-specific immune responses. U...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475716/ https://www.ncbi.nlm.nih.gov/pubmed/31020037 http://dx.doi.org/10.1016/j.omto.2019.03.007 |